Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nightly versus as-needed vardenafil in men with mild to mild-moderate erectile dysfunction
2005-001678-28Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (3 arms), sponsored by Bayer. Primary endpoint: Change from baseline in International Index of Erectile Function erectile function domain score. Started Aug 2005; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2005-001678-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001678-28.